Inhalation Drugs In Semipermeable Vials Need Individual Wrapping, FDA Says
Executive Summary
Inhalation drug products in semipermeable containers should be individually wrapped with secondary packaging to prevent environmental contamination of the drug product, an FDA draft guidance says
You may also be interested in...
Drug Contamination Data On Semipermeable Vials Should Be Collected By FDA
FDA needs to collect toxicology data on the potential contamination of drug products packaged in semipermeable containers, the agency's Drug Safety & Risk Management Advisory Committee recommended
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011